XTL Biopharmaceuticals Ltd. (TLV: XTLB)

XTL Biopharmaceuticals Market Cap

XTL Biopharmaceuticals has a market cap or net worth of 107.72 million as of October 16, 2024. Its market cap has increased by 434.30% in one year.

• Market Cap: 107.72M
• Enterprise Value: 99.09M
• Revenue: n/a
• Ranking: n/a
• PE Ratio: n/a
• Stock Price: 8.70

Market Cap Chart

Since August 30, 2005, XTL Biopharmaceuticals's market cap has decreased from 805.44M to 107.72M, a decrease of -86.63%. That is a compound annual growth rate of -9.98%.

Market Cap History

Date	Market Cap	% Change
Oct 15, 2024	107.72M	464.83%
Dec 31, 2023	19.07M	-14.63%
Dec 29, 2022	22.34M	-52.02%
Dec 30, 2021	46.56M	-7.60%
Dec 31, 2020	50.39M	108.51%
Dec 31, 2019	24.17M	-26.56%